A blocking monoclonal antibody reveals dimerization of intracellular domains of ALK2 associated with genetic disorders
Abstract Mutations in activin receptor-like kinase 2 (ALK2) can cause the pathological osteogenic signaling seen in some patients with fibrodysplasia ossificans progressiva and other conditions such as diffuse intrinsic pontine glioma. Here, we report that intracellular domain of wild-type ALK2 read...
Main Authors: | Takenobu Katagiri, Sho Tsukamoto, Mai Kuratani, Shinnosuke Tsuji, Kensuke Nakamura, Satoshi Ohte, Yoshiro Kawaguchi, Kiyosumi Takaishi |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-05-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-023-38746-5 |
Similar Items
-
Publisher Correction: A blocking monoclonal antibody reveals dimerization of intracellular domains of ALK2 associated with genetic disorders
by: Takenobu Katagiri, et al.
Published: (2023-09-01) -
Accumulated Knowledge of Activin Receptor-Like Kinase 2 (ALK2)/Activin A Receptor, Type 1 (ACVR1) as a Target for Human Disorders
by: Takenobu Katagiri, et al.
Published: (2021-06-01) -
Effects of FKBP12 and type II BMP receptors on signal transduction by ALK2 activating mutations associated with genetic disorders
by: Machiya, A, et al.
Published: (2018) -
Bone morphogenetic protein-induced heterotopic bone formation: What have we learned from the history of a half century?
by: Takenobu Katagiri, PhD, et al.
Published: (2015-05-01) -
Separation of monoclonal antibody alemtuzumab monomer and dimers using ultrafiltration.
by: Wan, Y, et al.
Published: (2005)